AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
P16 CDKN2 ALTERATIONS AND PRB EXPRESSION IN ESOPHAGEAL SQUAMOUS CARCINOMA/
Authors: BUSATTO G SHIAO YH PARENTI AR BAFFA R RUOL A PLEBANI M RUGGE M
Citation: G. Busatto et al., P16 CDKN2 ALTERATIONS AND PRB EXPRESSION IN ESOPHAGEAL SQUAMOUS CARCINOMA/, Journal of clinical pathology-Molecular pathology, 51(2), 1998, pp. 80-84
QUALITY-OF-LIFE AND FUNCTION OF THE ESOPHAGEAL SUBSTITUTE AFTER ESOPHAGECTOMY AND OESOPHAGO-GASTROSTOMY FOR ESOPHAGEAL CANCER
Authors: ZANINOTTO G COSTANTINI M RUOL A ANSELMINO M RENIER M MOLENA D NICOLETTI L CASARA D MERIGLIANO S ANCONA E
Citation: G. Zaninotto et al., QUALITY-OF-LIFE AND FUNCTION OF THE ESOPHAGEAL SUBSTITUTE AFTER ESOPHAGECTOMY AND OESOPHAGO-GASTROSTOMY FOR ESOPHAGEAL CANCER, British Journal of Surgery, 85, 1998, pp. 8-8
QUALITY-OF-LIFE AND FUNCTION OF THE ESOPHAGEAL SUBSTITUTE AFTER ESOPHAGECTOMY AND ESOPHAGO-GASTROSTOMY FOR ESOPHAGEAL CANCER
Authors: ZANINOTTO G COSTANTINI M RUOL A ANSELMINO M RENIER M MOLENA D NICOLETTI L CASARA D MERIGLIANO S ANCONA E
Citation: G. Zaninotto et al., QUALITY-OF-LIFE AND FUNCTION OF THE ESOPHAGEAL SUBSTITUTE AFTER ESOPHAGECTOMY AND ESOPHAGO-GASTROSTOMY FOR ESOPHAGEAL CANCER, British Journal of Surgery, 85, 1998, pp. 207-207
P53 ALTERATIONS BUT NO HUMAN PAPILLOMAVIRUS INFECTION IN PREINVASIVE AND ADVANCED SQUAMOUS ESOPHAGEAL CANCER IN ITALY
Authors: RUGGE M BOVO D BUSATTO G PARENTI AR FAWZY S GUIDO M ANCONA E NINFO V RUOL A SHIAO YH
Citation: M. Rugge et al., P53 ALTERATIONS BUT NO HUMAN PAPILLOMAVIRUS INFECTION IN PREINVASIVE AND ADVANCED SQUAMOUS ESOPHAGEAL CANCER IN ITALY, Cancer epidemiology, biomarkers & prevention, 6(3), 1997, pp. 171-176
BCL-2 AND P53 IMMUNOPHENOTYPES IN PREINVASIVE, EARLY AND ADVANCED ESOPHAGEAL SQUAMOUS CANCER
Authors: PARENTI AR RUGGE M SHIAO YH RUOL A ANCONA E BOZZOLA L NINFO V
Citation: Ar. Parenti et al., BCL-2 AND P53 IMMUNOPHENOTYPES IN PREINVASIVE, EARLY AND ADVANCED ESOPHAGEAL SQUAMOUS CANCER, Histopathology, 31(5), 1997, pp. 430-435
FIRST-LINE CHEMOTHERAPY IMPROVES THE RESECTION RATE AND LONG-TERM SURVIVAL OF LOCALLY ADVANCED (T4, ANY N, MO) SQUAMOUS-CELL CARCINOMA OF THE THORACIC ESOPHAGUS - FINAL REPORT ON 163 CONSECUTIVE PATIENTS WITH 5-YEAR FOLLOW-UP
Authors: ANCONA E RUOL A CASTORO C CHIARIONSILENI V MERIGLIANO S SANTI S BONAVINA L PERACCHIA A
Citation: E. Ancona et al., FIRST-LINE CHEMOTHERAPY IMPROVES THE RESECTION RATE AND LONG-TERM SURVIVAL OF LOCALLY ADVANCED (T4, ANY N, MO) SQUAMOUS-CELL CARCINOMA OF THE THORACIC ESOPHAGUS - FINAL REPORT ON 163 CONSECUTIVE PATIENTS WITH 5-YEAR FOLLOW-UP, Annals of surgery, 226(6), 1997, pp. 714-723
SERUM PROCOLLAGEN TYPE-III PEPTIDE IN CHRONIC HEPATITIS-B - RELATIONSHIP TO DISEASE-ACTIVITY AND RESPONSE TO INTERFERON-ALPHA THERAPY
Authors: GIUSTINA G FATTOVICH G DEPAOLI M GUIDO M FAVARATO S RUGGE M ALBERTI A RUOL A PLEBANI M
Citation: G. Giustina et al., SERUM PROCOLLAGEN TYPE-III PEPTIDE IN CHRONIC HEPATITIS-B - RELATIONSHIP TO DISEASE-ACTIVITY AND RESPONSE TO INTERFERON-ALPHA THERAPY, International journal of clinical & laboratory research, 26(1), 1996, pp. 33-36
A SURVEY OF ADVERSE EVENTS IN 11241 PATIENTS WITH CHRONIC VIRAL-HEPATITIS TREATED WITH ALFA INTERFERON
Authors: FATTOVICH G GIUSTINA G FAVARATO S RUOL A MACARRI G ORLANDI F IAQUINTO G AMBROSONE L FRANCAVILLA A PASTORE G SANTANTONIO MT ROMAGNO D BOLONDI L SOFIA S MARCHESINI A PISI E MAZZELLA G RODA E ATTARO L CHIODO F MORI F VERUCCHI G LANZINI A SALMI A CALVI B BOZZETTI F RADAELI E BERNASCONI M PILLERI G BACCA D ROMANO G MASTRAPASQUA G COZZOLONGO R CACOPARDO B NUNNARI A BLASI A SALA LO MINOLI G SANGIOVANNI A SPINZI GC COLOMBO A CAMASSA M RIVA D MAGGI G BOCCIA S GUALANDI G NUCCI A PACINI F MARINO N MAZZOTTA F LAMURA A POMPEI AG CASINELLI K PETROSILLO N GIACCHINO R TIMITILLI A SPIGA E CORSETTI M MENICAGLI V TUCCI A BISSOLI F RAIMONDO G RODINO G BELLOBUONO A IDEO G COLOMBO M PACCHETTI S RUMI MR BATTEZZATI PM BRUNO S PODDA M ZUIN M FARGION S FIORELLI G GELLMANN E VANDELLI C VENTURA E MANENTI F VILLA E CAPORASO N COLTORTI M MORISCO F DELVECCHIOBLANCO C DISANTOLO SS DINUNZIO S RUGGIERO G ZAMPINO R ASCIONE A DELUCA M GALEOTALANZA A APREA L SAGNELLI E FELACO FM PICCININO F BALLARE M MONTEVERDE A TAPPERO G SANNA G ALBERTI A BONETTI P CASARIN C DIODATI G TREMOLADA F NACCARATO R CHIARAMONTE M FLOREANI MR ALMASIO P CRAXI A LOIACONO O PAGLIARO L FIACCADORI F GIUBERTI T BELLONI G BERNARDINI E BUSCARINI L SBOLLI G GIUDICICIPRIANI A MARENCO G MAZZARO C MASSARI M FORNACIARI G PLANCHER A GASBARRINI G GRIECO A LUCHETTI R RAPACCINI GL BOMBARDIERI G DIVIRGILIO D BRUNO G RICCI GL HASSAN G MARI T SCALISI I COLLOREDO G FRUNZIO A TABONE M COSTA C ROSINA F SARACCO G VERME G FREZZA M URBAN F CAPRA F CASARIL M CORROCHER R BENETTI GP
Citation: G. Fattovich et al., A SURVEY OF ADVERSE EVENTS IN 11241 PATIENTS WITH CHRONIC VIRAL-HEPATITIS TREATED WITH ALFA INTERFERON, Journal of hepatology, 24(1), 1996, pp. 38-47
SERUM LEVELS OF SOLUBLE CD30 IN CHRONIC HEPATITIS-B VIRUS-INFECTION
Authors: FATTOVICH G VINANTE F GIUSTINA G MOROSATO L ALBERTI A RUOL A PIZZOLO G
Citation: G. Fattovich et al., SERUM LEVELS OF SOLUBLE CD30 IN CHRONIC HEPATITIS-B VIRUS-INFECTION, Clinical and experimental immunology, 103(1), 1996, pp. 105-110
EPIDERMAL GROWTH-FACTOR RECEPTORS AND ERBB2 PROTEIN EXPRESSION IN ESOPHAGEAL CANCER AND NORMAL MUCOSA
Authors: DITTADI R RUOL A GION M SEGALIN A PANOZZO M BRAZZALE A MEO S ANCONA E PERACCHIA A
Citation: R. Dittadi et al., EPIDERMAL GROWTH-FACTOR RECEPTORS AND ERBB2 PROTEIN EXPRESSION IN ESOPHAGEAL CANCER AND NORMAL MUCOSA, Oncology Reports, 2(3), 1995, pp. 381-385
THERAPEUTIC OPTIONS FOR CANCER OF THE HYPOPHARYNX AND CERVICAL ESOPHAGUS
Authors: BARDINI R RUOL A PERACCHIA A
Citation: R. Bardini et al., THERAPEUTIC OPTIONS FOR CANCER OF THE HYPOPHARYNX AND CERVICAL ESOPHAGUS, Annales chirurgiae et gynaecologiae, 84(2), 1995, pp. 202-207
P53 OVEREXPRESSION IN THE MULTISTEP PROCESS OF ESOPHAGEAL CARCINOGENESIS
Authors: PARENTI AR RUGGE M FRIZZERA E RUOL A NOVENTA F ANCONA E NINFO V
Citation: Ar. Parenti et al., P53 OVEREXPRESSION IN THE MULTISTEP PROCESS OF ESOPHAGEAL CARCINOGENESIS, The American journal of surgical pathology, 19(12), 1995, pp. 1418-1422
JUXTAGLOMERULAR CELL TUMOR OF THE KIDNEY
Authors: CAREGARO L MENON F GATTA A AMODIO P ARMANINI D FALLO F CORONA MC PESCARINI L RUOL A
Citation: L. Caregaro et al., JUXTAGLOMERULAR CELL TUMOR OF THE KIDNEY, Clinical and experimental hypertension, 16(1), 1994, pp. 41-53
ANASTOMOSIS
Authors: BARDINI R ASOLATI M RUOL A BONAVINA L BASEGGIO S PERACCHIA A
Citation: R. Bardini et al., ANASTOMOSIS, World journal of surgery, 18(3), 1994, pp. 373-378
TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT HUMAN INTERFERON-ALFA-2A - RELATIONSHIP BETWEEN BIOCHEMICAL RESPONSE AND HCV GENOTYPES
Authors: DIODATI G BONETTI P CASARIN C TAGGER A RIBERO ML TREMOLADA F REALDI G RUOL A
Citation: G. Diodati et al., TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT HUMAN INTERFERON-ALFA-2A - RELATIONSHIP BETWEEN BIOCHEMICAL RESPONSE AND HCV GENOTYPES, Hepatology, 20(4), 1994, pp. 10000343-10000343
HCV GENOTYPES AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C
Authors: DIODATI G TAGGER A BONETTI P CASARIN C RIBERO ML FASOLA M REALDI G RUOL A
Citation: G. Diodati et al., HCV GENOTYPES AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C, Hepatology, 19(4), 1994, pp. 90000058-90000058
TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT HUMAN INTERFERON-ALPHA-2A - RESULTS OF A RANDOMIZED CONTROLLED CLINICAL-TRIAL
Authors: DIODATI G BONETTI P NOVENTA F CASARIN C RUGGE M SCACCABAROZZI S TAGGER A POLLICE L TREMOLADA F DAVITE C REALDI G RUOL A
Citation: G. Diodati et al., TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT HUMAN INTERFERON-ALPHA-2A - RESULTS OF A RANDOMIZED CONTROLLED CLINICAL-TRIAL, Hepatology, 19(1), 1994, pp. 1-5
A RANDOMIZED CONTROLLED TRIAL OF THYMOPENTIN THERAPY IN PATIENTS WITHCHRONIC HEPATITIS-B
Authors: FATTOVICH G GIUSTINA G ALBERTI A GUIDO M PONTISSO P FAVARATO S BENVEGNU L RUOL A
Citation: G. Fattovich et al., A RANDOMIZED CONTROLLED TRIAL OF THYMOPENTIN THERAPY IN PATIENTS WITHCHRONIC HEPATITIS-B, Journal of hepatology, 21(3), 1994, pp. 361-366
INTERFERON ANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIC-C VIRUS-INFECTION TREATED WITH RECOMBINANT INTERFERON ALPHA-2-ALPHA
Authors: BONETTI P DIODATI G DRAGO C CASARIN C SCACCABAROZZI S REALDI G RUOL A ALBERTI A
Citation: P. Bonetti et al., INTERFERON ANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIC-C VIRUS-INFECTION TREATED WITH RECOMBINANT INTERFERON ALPHA-2-ALPHA, Journal of hepatology, 20(3), 1994, pp. 416-420
RELATIONSHIP BETWEEN SERUM HCV MARKERS AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C - EVALUATION OF HCV GENOTYPES DURING AND AFTER LONG-TERM FOLLOW-UP
Authors: DIODATI G BONETTI P TAGGER A CASARIN C NOVENTA F RIBERO M FASOLA M RUOL A REALDI G
Citation: G. Diodati et al., RELATIONSHIP BETWEEN SERUM HCV MARKERS AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C - EVALUATION OF HCV GENOTYPES DURING AND AFTER LONG-TERM FOLLOW-UP, Digestive diseases and sciences, 39(11), 1994, pp. 2497-2502
SINGLE-LAYERED CERVICAL ESOPHAGEAL ANASTOMOSES - A PROSPECTIVE-STUDY OF 2 SUTURING TECHNIQUES
Authors: BARDINI R BONAVINA L ASOLATI M RUOL A CASTORO C TISO E
Citation: R. Bardini et al., SINGLE-LAYERED CERVICAL ESOPHAGEAL ANASTOMOSES - A PROSPECTIVE-STUDY OF 2 SUTURING TECHNIQUES, The Annals of thoracic surgery, 58(4), 1994, pp. 1087-1089
DEVELOPMENT AND VALIDATION OF A PROGNOSTIC INDEX PREDICTING DEATH AFTER UPPER GASTROINTESTINAL-BLEEDING IN PATIENTS WITH LIVER-CIRRHOSIS - A MULTICENTER STUDY
Authors: GATTA A MERKEL C AMODIO P BELLON S BELLUMAT A BOLOGNESI M BORSATO L BUTTO M CASSON FF CAVALLARIN G CIELO R CRISTINA P CUCCI E DONADA C DONADON V ENZO E MARIN R MAZZARO C MIORI R NOVENTA F TORBOLI P RUOL A
Citation: A. Gatta et al., DEVELOPMENT AND VALIDATION OF A PROGNOSTIC INDEX PREDICTING DEATH AFTER UPPER GASTROINTESTINAL-BLEEDING IN PATIENTS WITH LIVER-CIRRHOSIS - A MULTICENTER STUDY, The American journal of gastroenterology, 89(9), 1994, pp. 1528-1536
CORRELATION OF P53 MUTATIONS WITH EPIDERMAL GROWTH-FACTOR RECEPTOR OVEREXPRESSION AND ABSENCE OF MDM2 AMPLIFICATION IN HUMAN ESOPHAGEAL CARCINOMAS
Authors: ESTEVE A LEHMAN T JIANG W WEINSTEIN IB HARRIS CC RUOL A PERACCHIA A MONTESANO R HOLLSTEIN M
Citation: A. Esteve et al., CORRELATION OF P53 MUTATIONS WITH EPIDERMAL GROWTH-FACTOR RECEPTOR OVEREXPRESSION AND ABSENCE OF MDM2 AMPLIFICATION IN HUMAN ESOPHAGEAL CARCINOMAS, Molecular carcinogenesis, 8(4), 1993, pp. 306-311
TREATMENT WITH INTERFERON(S) OF COMMUNITY-ACQUIRED CHRONIC HEPATITIS AND CIRRHOSIS TYPE-C
Authors: ALBERTI A CHEMELLO L BONETTI P CASARIN C DIODATI G CAVALLETTO L CAVALLETTO D FREZZA M DONADA C BELUSSI F CASARIN P POZZATO G RUOL A
Citation: A. Alberti et al., TREATMENT WITH INTERFERON(S) OF COMMUNITY-ACQUIRED CHRONIC HEPATITIS AND CIRRHOSIS TYPE-C, Journal of hepatology, 17, 1993, pp. 123-126
FLOW CYTOMETRIC DNA ANALYSIS DOES NOT PREDICT THE RADIOCHEMORESPONSIVENESS OF ESOPHAGEAL CANCER
Authors: SEGALIN A RUOL A PANOZZO M BONAVINA L BIANCHI LC PERACCHIA A
Citation: A. Segalin et al., FLOW CYTOMETRIC DNA ANALYSIS DOES NOT PREDICT THE RADIOCHEMORESPONSIVENESS OF ESOPHAGEAL CANCER, Journal of surgical oncology, 54(2), 1993, pp. 87-90
Risultati: 1-25 | 26-26